China Biologic Products (CBPO) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts CBPO Hot Sheet
Join SI Premium – FREE
China Biologic Products (NASDAQ: CBPO) reported Q2 EPS of $1.35, $0.01 worse than the analyst estimate of $1.36. Revenue for the quarter came in at $89.3 million versus the consensus estimate of $96.47 million.
Guidance:
FY 2017 revenue up 13-15%
For earnings history and earnings-related data on China Biologic Products (CBPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Some Said Inflation Risks Had Become More Skewed To Upside - FOMC Minutes
- Apogee Enterprises (APOG) Tops Q2 EPS by 54c ; Offers Guidance
- Penguin Solutions (PENG) Tops Q4 EPS by 23c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
